Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BTB domain-containing protein 18 (BTBD18) is a protein primarily expressed in the testis, and is specifically required during spermatogenesis to promote the transcription of precursor piRNAs[1][3][5][7]. It acts in the nucleus, facilitating transcription elongation at piRNA loci during male meiosis, which is critical for the repression of transposable elements in germ cells[1][5][7]. Mouse deficiency studies indicate a key requirement for BTBD18 in spermiogenesis, as knock-out leads to increased germ cell apoptosis and male infertility[9]. There is no evidence that BTBD18 serves as a pharmacological target (e.g., receptor, enzyme) or is currently drugged; it is a structural and regulatory protein in the BTB/POZ protein family, which is known for protein-protein interactions and gene regulatory roles[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BTB domain-containing protein 18 (BTBD18).